PortfoliosLab logoPortfoliosLab logo
AYA.TO vs. TGTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AYA.TO vs. TGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Aya Gold & Silver Inc. (AYA.TO) and TG Therapeutics, Inc. (TGTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

AYA.TO is traded in CAD, while TGTX is traded in USD. To make them comparable, the TGTX values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, AYA.TO achieves a 33.04% return, which is significantly lower than TGTX's 69.66% return. Over the past 10 years, AYA.TO has outperformed TGTX with an annualized return of 46.86%, while TGTX has yielded a comparatively lower 22.67% annualized return.


AYA.TO

1D
7.49%
1M
-10.88%
YTD
33.04%
6M
24.61%
1Y
98.56%
3Y*
42.66%
5Y*
25.69%
10Y*
46.86%

TGTX

1D
3.36%
1M
18.56%
YTD
69.66%
6M
60.38%
1Y
35.63%
3Y*
23.56%
5Y*
8.68%
10Y*
22.67%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AYA.TO vs. TGTX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AYA.TO
Aya Gold & Silver Inc.
33.04%82.87%10.61%7.65%-5.55%148.05%97.44%2.09%16.46%192.86%
TGTX
TG Therapeutics, Inc.
69.66%-5.48%91.15%40.94%-33.79%-63.49%357.53%159.57%-45.80%64.40%

Correlation

The correlation between AYA.TO and TGTX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.05

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (10Y)
Calculated over the trailing 10-year period

0.07

Correlation (All Time)
Calculated using the full available price history since May 3, 2010

0.05

Fundamentals

Market Cap

AYA.TO:

CA$3.88B

TGTX:

$7.93B

EPS

AYA.TO:

$0.60

TGTX:

$2.87

PE Ratio

AYA.TO:

31.07

TGTX:

17.23

PEG Ratio

AYA.TO:

0.06

TGTX:

0.03

PS Ratio

AYA.TO:

9.44

TGTX:

11.37

PB Ratio

AYA.TO:

6.06

TGTX:

13.59

Total Revenue (TTM)

AYA.TO:

$283.62M

TGTX:

$700.35M

Gross Profit (TTM)

AYA.TO:

$155.19M

TGTX:

$581.54M

EBITDA (TTM)

AYA.TO:

$167.72M

TGTX:

$156.88M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AYA.TO vs. TGTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AYA.TO
AYA.TO Risk / Return Rank: 7878
Overall Rank
AYA.TO Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
AYA.TO Sortino Ratio Rank: 7575
Sortino Ratio Rank
AYA.TO Omega Ratio Rank: 7373
Omega Ratio Rank
AYA.TO Calmar Ratio Rank: 8080
Calmar Ratio Rank
AYA.TO Martin Ratio Rank: 8181
Martin Ratio Rank

TGTX
TGTX Risk / Return Rank: 6363
Overall Rank
TGTX Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 6464
Sortino Ratio Rank
TGTX Omega Ratio Rank: 6363
Omega Ratio Rank
TGTX Calmar Ratio Rank: 6464
Calmar Ratio Rank
TGTX Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AYA.TO vs. TGTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aya Gold & Silver Inc. (AYA.TO) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AYA.TOTGTXDifference
Sharpe ratioReturn per unit of total volatility

+0.52

Sortino ratioReturn per unit of downside risk

+0.51

Omega ratioGain probability vs. loss probability

1.23

1.17

+0.06

Calmar ratioReturn relative to maximum drawdown

2.39

1.11

+1.29

Martin ratioReturn relative to average drawdown

6.46

2.04

+4.42

AYA.TO vs. TGTX - Sharpe Ratio Comparison

The current AYA.TO Sharpe Ratio is 1.27, which is higher than the TGTX Sharpe Ratio of 0.75. The chart below compares the historical Sharpe Ratios of AYA.TO and TGTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AYA.TO vs. TGTX - Drawdown Comparison

The maximum AYA.TO drawdown since its inception was -81.67%, smaller than the maximum TGTX drawdown of -99.53%. Use the drawdown chart below to compare losses from any high point for AYA.TO and TGTX.


Loading charts...

Drawdown Indicators


AYA.TOTGTXDifference

Max Drawdown

Largest peak-to-trough decline

-81.67%

-99.53%

+17.86%

Max Drawdown (1Y)

Largest decline over 1 year

-41.38%

-32.35%

-9.03%

Max Drawdown (3Y)

Largest decline over 3 years

-54.86%

-74.70%

+19.84%

Max Drawdown (5Y)

Largest decline over 5 years

-54.91%

-90.47%

+35.56%

Max Drawdown (10Y)

Largest decline over 10 years

-72.30%

-93.15%

+20.85%

Current Drawdown

Current decline from peak

-12.23%

-71.21%

+58.98%

Average Drawdown

Average peak-to-trough decline

-37.46%

-89.91%

+52.45%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.31%

17.51%

-2.20%

Volatility

AYA.TO vs. TGTX - Volatility Comparison

Aya Gold & Silver Inc. (AYA.TO) has a higher volatility of 30.47% compared to TG Therapeutics, Inc. (TGTX) at 15.70%. This indicates that AYA.TO's price experiences larger fluctuations and is considered to be riskier than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AYA.TOTGTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

30.47%

15.70%

+14.77%

Volatility (6M)

Calculated over the trailing 6-month period

58.25%

34.47%

+23.78%

Volatility (1Y)

Calculated over the trailing 1-year period

77.96%

47.92%

+30.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

67.63%

88.35%

-20.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.63%

87.43%

-9.80%

Dividends

AYA.TO vs. TGTX - Dividend Comparison

Neither AYA.TO nor TGTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

AYA.TO vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between Aya Gold & Silver Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M20222023202420252026
115.35M
204.92M
(AYA.TO) Total Revenue
(TGTX) Total Revenue
Values in USD except per share items

AYA.TO vs. TGTX - Profitability Comparison

The chart below illustrates the profitability comparison between Aya Gold & Silver Inc. and TG Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%100.0%20222023202420252026
71.3%
83.7%
Portfolio components
AYA.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aya Gold & Silver Inc. reported a gross profit of 82.27M and revenue of 115.35M. Therefore, the gross margin over that period was 71.3%.

TGTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.

AYA.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aya Gold & Silver Inc. reported an operating income of 76.31M and revenue of 115.35M, resulting in an operating margin of 66.2%.

TGTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.

AYA.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aya Gold & Silver Inc. reported a net income of 47.54M and revenue of 115.35M, resulting in a net margin of 41.2%.

TGTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.


Frequently Asked Questions


AYA.TO and TGTX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for AYA.TO and TGTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer